These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36214033)

  • 41. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
    Gordon SF; Virah Sawmy E; Duckworth E; Wolthuizen M; Clothier HJ; Chea M; Tenneti N; Blow N; Buttery JP; de Luca J; Korman TM; Barnes S; Slade C; Maggs C; Giles ML; Teh BW; Aboltins C; Langan KM; Van Diemen A; Crawford NW
    Hum Vaccin Immunother; 2022 Nov; 18(5):2052701. PubMed ID: 35471988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parental Declaration of Adverse Event Following Immunization in a Cross-Sectional Study in Poland.
    Barański K; Gajda M; Braczkowska B; Kowalska M
    Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31652499
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parental perspectives of vaccine safety and experience of adverse events following immunisation.
    Parrella A; Gold M; Marshall H; Braunack-Mayer A; Baghurst P
    Vaccine; 2013 Apr; 31(16):2067-74. PubMed ID: 23422146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Barriers to healthcare workers reporting adverse events following immunization in Zhejiang province, China.
    Lv H; Pan X; Wang Y; Liang H; Yu H
    Hum Vaccin Immunother; 2022 Nov; 18(5):2083865. PubMed ID: 35820038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
    Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
    Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
    Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
    Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
    [No Abstract]   [Full Text] [Related]  

  • 48. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
    Masuka JT; Khoza S
    BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study.
    Harry AM; Edet CK; Ekanem NE; Kemdirim CJ; Uduak AE
    Niger Postgrad Med J; 2022; 29(2):89-95. PubMed ID: 35488575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 vaccination: Is it a matter of concern?
    Kushwaha P; Pundhir A; Gahlot A
    J Family Med Prim Care; 2022 Jun; 11(6):2431-2436. PubMed ID: 36119229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adverse events following immunization against SARS-CoV-2 (covid-19) in the state of Minas Gerais.
    Silva RBD; Silva TPRD; Sato APS; Lana FCF; Gusmão JD; Souza JFA; Matozinhos FP
    Rev Saude Publica; 2021; 55():66. PubMed ID: 34706042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse events following COVID-19 immunisation (AEFI) at a COVID-19 vaccination centre: An observational analytical study.
    Shukla V; Sachan B; Jauhari S; Bhardwaj S; Pathak A; Kandpal SD
    J Family Med Prim Care; 2023 Mar; 12(3):460-465. PubMed ID: 37122665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess.
    Yamoah P; Mensah KB; Attakorah J; Padayachee N; Oosthuizen F; Bangalee V
    Hum Vaccin Immunother; 2022 Nov; 18(6):2109365. PubMed ID: 35947052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.
    Crooks CJ; Prieto-Merino D; Evans SJ
    Drug Saf; 2012 Jan; 35(1):61-78. PubMed ID: 22136183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy.
    Valletta M; Canevelli M; D'Antonio F; Trebbastoni A; Talarico G; Campanelli A; Sepe Monti M; Di Vita A; Salati E; Imbriano L; Margiotta R; Barbetti S; Diana S; Buscarnera S; Toccaceli Blasi M; Salzillo M; Pugliese G; Vanacore N; Bruno G
    J Alzheimers Dis; 2022; 87(4):1467-1474. PubMed ID: 35431254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central nervous system adverse events after ChAdOx1 vaccination.
    Maramattom BV; Lotlikar RS; Sukumaran S
    Neurol Sci; 2022 Jun; 43(6):3503-3507. PubMed ID: 35275317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.
    Ferrara F; Mancaniello C; Varriale A; Sorrentino S; Zovi A; Nava E; Trama U; Boccellino M; Vitiello A
    Clin Drug Investig; 2022 Dec; 42(12):1065-1074. PubMed ID: 36274082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study.
    Islam MR; Hasan M; Nasreen W; Tushar MI; Bhuiyan MA
    Int J Immunopathol Pharmacol; 2021; 35():20587384211065628. PubMed ID: 34911394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.